Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
MA05 - Improving Outcomes in Locoregional NSCLC II
- 13:30 - 15:00
- 9/24/2018
- Location: Room 105
- Type: Mini Oral Abstract Session
- Track: Treatment of Locoregional Disease - NSCLC
-
+
MA05.01 - E6508: Phase II Study of Immunotherapy with Tecemotide and Bevacizumab after Chemoradiation in Unresectable Stage III NS-NSCLC
13:30 - 13:35 | Presenter: Jyoti Patel | Author(s): Ju-Whei Lee, Henry Wagner Jr, David P Carbone, Anil Shanker, Leora Horn, Melissa L. Johnson, David E Gerber, Jane Jijun Liu, Millie S Das, Mohammad Ali Al-Nsour, Christopher S R Dakhil, Suresh S. Ramalingam, Joan Schiller
- Abstract
Loading...
-
+
MA06 - PDL1, TMB and DNA Repair
- 13:30 - 15:00
- 9/24/2018
- Location: Room 206 AC
- Type: Mini Oral Abstract Session
- Track: Biology
-
+
MA06.08 - Discussant - MA 06.05, MA 06.06, MA 06.07
14:15 - 14:30 | Presenter: Jyoti Patel
- Abstract
No abstract available for this presentation
-
+
MA21 - Molecular Subtyping, CBL3, and Non Coding RNA
- 15:15 - 16:45
- 9/25/2018
- Location: Room 205 BD
- Type: Mini Oral Abstract Session
- Track: Biology
-
+
MA21.11 - Epigenomic Mapping of Cell-Free DNA in Patients with Non-Small Cell Lung Cancer
16:25 - 16:30 | Presenter: Christine M Bestvina | Author(s): Jordan Karpus, Xiao-long Cui, Claire Oosterbaan, Brian Won, Chuan He, Jyoti Patel
- Abstract
Loading...
-
+
OA12 - Novel Therapies in MET, RET and BRAF
- 15:15 - 16:45
- 9/25/2018
- Location: Room 106
- Type: Oral Abstract Session
- Track: Targeted Therapy
-
+
OA12.01 - Phase II Data for the MET Inhibitor Tepotinib in Patients with Advanced NSCLC and MET Exon 14-Skipping Mutations
15:15 - 15:25 | Presenter: Enriqueta Felip | Author(s): Hiroshi Sakai, Jyoti Patel, Leora Horn, Remi Veillon, Frank Griesinger, Rolf Bruns, Jürgen Scheele, Paul K. Paik
- Abstract
Loading... -
+
OA12.07 - Clinical Activity of LOXO-292, a Highly Selective RET Inhibitor, in Patients with RET Fusion+ Non-Small Cell Lung Cancer
16:20 - 16:30 | Presenter: Geoffrey R. Oxnard | Author(s): Vivek Subbiah, Keunchil Park, Todd M. Bauer, Lori J Wirth, Vamsidhar Velcheti, Manisha Shah, Benjamin Besse, Valentina Boni, Karen L. Reckamp, Herbert H Loong, Lyudmila Bazhenova, Ben J Solomon, Daniel S.W. Tan, Jyoti Patel, Melissa L. Johnson, Anas Gazzah, Tony S. Mok, Steve Smith, Brian Tuch, Kevin Ebata, Edward Y Zhu, Michele M Nguyen, Xin Huang, Scott Cruickshank, S Michael Rothenberg, Alexander Drilon
- Abstract
Loading...